Feher MD - Search Results

1

How Generalizable Are Cardiovascular Outcome Trials of Sodium-Glucose Co-Transporter-2 Inhibitors? A National Database Study: Study Protocol.

Hinton W, Feher MD, Munro N, de Lusignan S. Hinton W, et al. Among authors: feher md. Diabetes Ther. 2019 Jun;10(3):1163-1170. doi: 10.1007/s13300-019-0620-8. Epub 2019 Apr 30. Diabetes Ther. 2019. PMID: 31041781 Free PMC article.

2

Current, new, and emerging therapies for managing hyperglycaemia in type 2 diabetes.

Munro N, Feher MD. Munro N, et al. Among authors: feher md. Br J Gen Pract. 2008 Aug;58(553):531-3. doi: 10.3399/bjgp08X319684. Br J Gen Pract. 2008. PMID: 18682016 Free PMC article. No abstract available.

3

Fixed-dose combinations in diabetes--do they improve medication adherence?

Feher MD, Munro N, Watters K. Feher MD, et al. Diabet Med. 2010 Jul;27(7):735-6. doi: 10.1111/j.1464-5491.2010.03023.x. Diabet Med. 2010. PMID: 20636951 No abstract available.

4

QTc prolongation and diabetes therapies.

Watters K, Munro N, Feher M. Watters K, et al. Diabet Med. 2012 Mar;29(3):290-2. doi: 10.1111/j.1464-5491.2011.03520.x. Diabet Med. 2012. PMID: 22060961 No abstract available.

5

Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus.

Feher M, Greener M, Munro N. Feher M, et al. Diabetes Metab Syndr Obes. 2013;6:11-5. doi: 10.2147/DMSO.S35053. Epub 2013 Jan 10. Diabetes Metab Syndr Obes. 2013. PMID: 23341741 Free PMC article.

6

Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Comparing Trial and Real World Use (Study Protocol).

McGovern A, Feher M, Munro N, de Lusignan S. McGovern A, et al. Diabetes Ther. 2017 Apr;8(2):355-363. doi: 10.1007/s13300-017-0229-8. Epub 2017 Jan 30. Diabetes Ther. 2017. PMID: 28138853 Free PMC article.

7

Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use.

McGovern A, Feher M, Munro N, de Lusignan S. McGovern A, et al. Diabetes Ther. 2017 Apr;8(2):365-376. doi: 10.1007/s13300-017-0254-7. Epub 2017 Mar 21. Diabetes Ther. 2017. PMID: 28324484 Free PMC article.

8

Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study Protocol.

Hinton W, Feher M, Munro N, de Lusignan S. Hinton W, et al. Diabetes Ther. 2018 Jun;9(3):1397-1402. doi: 10.1007/s13300-018-0390-8. Epub 2018 Mar 31. Diabetes Ther. 2018. PMID: 29605893 Free PMC article.

9

Novel diabetes subgroups.

Feher MD, Munro N, Russell-Jones D, de Lusignan S, Khunti K. Feher MD, et al. Lancet Diabetes Endocrinol. 2018 Jun;6(6):439. doi: 10.1016/S2213-8587(18)30126-8. Lancet Diabetes Endocrinol. 2018. PMID: 29803263 No abstract available.

10

Variation in the diagnosis and control of hypertension is not explained by conventional variables: Cross-sectional database study in English general practice.

Coyle R, Feher M, Jones S, Hamilton M, de Lusignan S. Coyle R, et al. PLoS One. 2019 Jan 10;14(1):e0210657. doi: 10.1371/journal.pone.0210657. eCollection 2019. PLoS One. 2019. PMID: 30629703 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters